Sikora Lab

welcome to the sikora lab

The Sikora Lab was launched in August 2016. As a new research group, we strive to create an environment where our staff and early-career researchers (ECRs; students, postdocs, and fellows) can advance both our collective research efforts and their own unique training and career development goals.

OUR MISSION

AT THE BENCH​​

​Understand steroid hormone signaling in cancer, with a focus on response to endocrine therapy and anti-estrogen resistance in breast cancer.

Understand steroid hormone signaling mechanisms in invasive lobular carcinoma of the breast.​

TOWARD THE CLINIC​​

​Improve the outcomes of patients with hormone-dependent breast cancer and other cancers primarily affecting women.

FOR OUR RESEARCH COMMUNITY​​

​Train productive, collaborative, and responsible members of the scientific community.


RECENT ANNOUNCEMENTS

Accepting Students

We are recruiting graduate students from these CU Anschutz PhD programs:

Biomedical Sciences Program | Cancer Biology | Pharmacology | ​Molecular Biology

Still in college? Contact us for undergraduate research opportunities or check out a list of programs here.

Publications

Read the Sikora Lab's recent work on estrogen receptor function in lobular carcinoma.

Featured on the August 2021 cover of Molecular Cancer Research

Grants and Awards

Golfers Against Cancer (GAC) - Denver: The Sikora Lab received a pilot grant from GAC to advance our WNT4 research toward developing new treatments for ovarian cancer, and understanding patient risk of developing ovarian cancer.

Lobular Breast Cancer Alliance (LBCA): Dr. Sikora joined the #lobmob as a member of the Scientific Advisory Board. Working closely with ILC patient advocates keeps our research focused on the needs of patients!


FOLLOW US ON TWITTER

The PI: @mjsikora

The Lab: @SikoraLab